# Secretin (ChiRhoStim) Pancreas Perfusion for Pancreatic Adenocarcinoma

> **NCT00587132** · PHASE1,PHASE2 · TERMINATED · sponsor: **Mayo Clinic** · enrollment: 4 (actual)

## Conditions studied

- Pancreatic Cancer

## Interventions

- **DRUG:** Synthetic Human Secretin

## Key facts

- **NCT ID:** NCT00587132
- **Lead sponsor:** Mayo Clinic
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2006-11
- **Primary completion:** 2012-02
- **Final completion:** 2012-02
- **Target enrollment:** 4 (ACTUAL)
- **Why stopped:** Lack of funding
- **Last updated:** 2013-06-24

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00587132

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00587132, "Secretin (ChiRhoStim) Pancreas Perfusion for Pancreatic Adenocarcinoma". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT00587132. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*